Abstract
An imperative of a professional practice is to ensure transformations. Identifying opportunities in evolvements of healthcare systems and being cognisant of changes in expectations of society warrants validity and relevance of the professional practice. This is what we have witnessed in hospital and community pharmacy. The chapter briefly contemplates how clinical pharmacy and pharmaceutical care have shaped the provision of direct patient care services and expanded the scope of hospital and community pharmacy practice. Innovations in practice such as use of robotics and collaborative practice are put forward. Domains are outlined to describe relevant competences and provide an insight into professional characteristics that support practising as hospital and community pharmacists. Attributes that lead to professional fulfilment are considered, and experiences and prospects for specialisation and professional development to become advanced practitioners are described. Advancement in pharmacy education and participation in translational research and implementation science contribute to pharmacist capacity building and empowerment to approach the transformation of pharmacy practice for the next decades. Emphasis is given to describe attributes of successful hospital and community pharmacy practice by highlighting the patient-centric goal, collaborative model, safe culture, digitalisation and entrepreneurship.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Pharmaceutical Group of European Union. Position paper on the role of community pharmacists in COVID-19—Lessons learnt from the pandemic. www.pgeu.eu
References
Almansour HA, Aloudah NM, Alhawassi TM, Chaar B, Krass I, Saini B (2021) Cardiovascular disease risk prevention services by pharmacists in Saudi Arabia: what do policymakers and opinion leaders think? J Pharm Policy Pract 14:42
Almohammde S, Alhodian H, Almofareh S, Alshehri S, Almasri DM, Ghoneim RH (2021) A survey of therapeutic drug monitoring in a teaching hospital. Saudi J Biol Sci 28:744–747
American College of Clinical Pharmacy (ACCP) (2014) Standards of practice for clinical pharmacists. Pharmacotherapy 34(8):794–797
American Society of Health-System Pharmacists (2013) ASHP guidelines: minimum standard for pharmacies in hospitals. Am J Health Syst Pharm 70:1619–1630
Atayee RS, Awdishu L, Namba J (2016) Using simulation to improve first-year pharmacy students’ ability to identify medication errors involving the top 100 prescription medications. Am J Pharm Educ 80(5):article 86
Azzopardi LM (2000) Validation instruments for community pharmacy: pharmaceutical care for the third millennium. Pharmaceutical Products Press, New York
Azzopardi LM (2019) Pharmacy practice in Western Europe. In: Babar Z (ed) Encylopedia of pharmacy practice and clinical pharmacy. Elsevier, Oxford, pp 478–487
Azzopardi LM, Serracino-Inglott A (2020) Clinical pharmacy education and practice evolvement in Malta. J Am Coll Clin Pharm 3:973–979
Bacci JL, Klepser D, Tilley H, Smith JK, Klepser ME (2018) Community pharmacy-based point-of-care testing: a case study of pharmacist-physician collaborative working relationships. Res Soc Adm Pharm 14:112–115
Bauman JL, Manasse HR (2019) Clinical pharmacy practice in community pharmacies: a frontier with promise? J Am Coll Clin Pharm 2:326–329
Bayraktar-Ekincioglu A, Korobuk G, Demirkan K (2018) An evaluation of chemotherapy drug preparation process in hospitals in Turkey—a pilot study. J Oncol Pharm Pract 24(8):563–573
Bell J, Dziekan G, Pollack C, Mahachai V (2016) Self-care in the twenty first century: a vital role for the pharmacist. Adv Ther 33:1691–1703
Bhakta SB, Colavecchia AC, Coffey W, Curlee DR, Garey KW (2018) Implementation and evaluation of a sterile compounding robot in a satellite oncology pharmacy. Am J Health Syst Pharm 75:S51–S57
Blazar D, Kraft MA (2017) Teacher and teaching effects on students’ attitudes and behaviors. Educ Eval Policy Anal 39:146–170
Bourdin A, Schluep M, Bugnon O, Berger J (2019) Promoting transitions of care, safety, and medication adherence for patients taking fingolimod in community pharmacies. Am J Health Syst Pharm 76:1150–1157
Bronkhorst E, Gous AGS, Schellack N (2020) Practice guidelines for clinical pharmacists in middle to low income countries. Front Pharmacol 11:article 978
Bruno Xuereb A, Wirth F, Mifsud Buhagiar L, Camilleri L, Azzopardi LM, Serracino-Inglott A (2022) Pharmacist and physician perception of pharmacogenetic testing. Int J Pharm Pract 30(2):188–191
Carter BL (2016) Evolution of clinical pharmacy in the US and future directions for patient care. Drugs Aging 33(3):169–177
Clay PG (2016) “Pitching” pharmacists as improvers of transition-of-care outcomes. J Am Pharm Assoc 56:348
Dang YH, To-Lui KP (2020) Pharmacist perceptions of and views on postgraduate year 3 training. Am J Health-Syst Pharm 77(18):1488–1496
DiPiro J (2011) Preparing our students for the many opportunities in pharmacy. Am J Pharm Educ 75(9):article 170
Dubbai H, Adelstein BA, Taylor S, Shulruf B (2019) Definition of professionalism and tools for assessing professionalism in pharmacy practice: a systematic review. J Educ Eval Health Prof 16:22
Eickhoff C, Schulz M (2006) Pharmaceutical care in community pharmacies: practice and research in Germany. Ann Pharmacother 40:729–735
Eickhoff C, Griese-Mammen N, Mueller U, Said A, Schulz M (2021) Primary healthcare policy and vision for community pharmacy and pharmacists in Germany. Pharm Pract 19(1):2248
Erstad BL, Webb CE (2020) A brief history of pharmacy specialization in the United States. J Am Coll Clin Pharm 3:1464–1470
Estellat C, Colombet I, Vautier S, Huault-Quentel J, Durieux P, Sabatier B (2007) Impact of pharmacy validation in a computerised physician order entry context. Int J Qual Health Care 19:317–325
European Association of Faculties of Pharmacy (2018) EAFP position paper. EAFP, Parma
European Association of Hospital Pharmacists (EAHP) (2014) The European statements of hospital pharmacy. Eur J Hosp Pharm 21:256–258
Falzon S, Galea N, Calvagna V, Pham JT, Grech L, Azzopardi LM (2021) Development and use of an innovative gap finding tool to create pharmaceutical care model within a paediatric oncology setting. J Oncol Pharm Pract. https://doi.org/10.1177/10781552211053249
Felkery BG, Fox BI (2012) Pharmacy automation and technology: how patient-centric is your practice? Hosp Pharm 47:310–311
Firman P, Whitfield K, Tan KS, Clavarino A, Hay K (2021) The impact of an electronic hospital system on therapeutic drug monitoring. J Clin Pharm Ther 46:1613–1621
Francke DE, Latiolais CJ, Francke GN, Ho NF (1964) Mirror to hospital pharmacy. American Society of Hospital Pharmacists, Washington, DC
Frontini R, Miharija-Gala T, Sykora J (2013) EAHP survey 2010 on hospital pharmacy in Europe: parts 4 ad 5. Clinical services and patient safety. Eur J Hosp Pharm 20:69–73
Galea S, Zarb-Adami M, Serracino-Inglott A, Azzopardi LM (2014) Pharmacist intervention in non-prescription medicine use. JPHRS 5:55–59
Gauci M, Wirth F, Azzopardi LM, Serracino-Inglott A (2019) Clinical pharmacist implementation of a medication assessment tool for long-term management of atrial fibrillation in older persons. Pharm Pract 17(1):1349
Grech L, Ferrito V, Serracino-Inglott A, Azzopardi LM (2016) Development and validation of RhMAT, as medication assessment tool specifically designed for rheumatoid arthritis management. JPHRS 7:89–92
Hendrikse H, Kiss O, Kunikowska J, Wadsak W, Decristofor C, Patt M (2022) EANM position on the in-house preparation of radiopharmaceuticals. Eur J Nucl Med Mol Imaging 49:1095–1098
Hepler CD (1985) Pharmacy as a clinical profession. Am J Hosp Pharm 42:1298–1306
Hepler CD, Strand LM (1990) Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47:533–543
Hicks JK, Aquilante CL, Dunnenberger HM, Gammal RS, Funk RS, Aitken SL, Bright DR, Coons JC, Dotson KM, Elder CT, Groff LT, Lee JC (2019) Precision pharmacotherapy: integrating pharmacogenomics into clinical pharmacy practice. J Am Coll Clin Pharm 2:303–313
Higby GJ (2014) A cornerstone of modern institutional pharmacy practice: mirror to hospital pharmacy. Am J Health Syst Pharm 71:1940–1946
International Pharmaceutical Federation (FIP) (2012) FIP global pharmacy workforce report, vol 2012. FIP, The Netherlands, p 18
Jeong S, Ji E (2018) Global perspectives on ensuring the safety of pharmaceutical products in the distribution process. Int J Clin Pharm Ther 56:12–23
Jepsen DM, Spooner O’Neill M (2013) Australian hospital pharmacists reflect on career success. J Pharm Pract Res 43:29–31
Joseph K, Ramireddy K, Madison G, Turco T, Lui M (2021a) Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital. J Clin Pharm Ther 46:1103–1108
Joseph T, Hale GM, Moreau C (2021b) Training pharmacy residents as transitions of care specialists: a United States perspective. Int J Clin Pharm 43:756–758
Jusufoska M, Abreu de Azevedo M, Tolic J, Deml MJ, Tarr PE (2021) ‘Vaccination needs to be easy for the people, right?’ A qualitative study of the roles of physicians and pharmacists regarding vaccination in Switzerland. BMJ Open 11:e053163
Karnes JH, Asempa T, Barreto JN, Belcher RM, Bissell BD, Gammal RS, Kier KL, Lee CR, Liu L, McCune JS, Minhaj FS, Sikora Newsome A, Ning J, Bookstaver PB (2022) The essential research curriculum for doctor of pharmacy degree programs 2021. J Am Coll Clin Pharm 5:358–365. https://doi.org/10.1002/jac5.1603
Katangwe T, Family H, Sokhi J, Kirkdale CL, Twigg MJ (2020) The community pharmacy setting for diabetes prevention: a mixed methods study in people with ‘pre-diabetes’. Res Soc Adm Pharm 16:1067–1080
Katoue MG, Schwinghammer TL (2020) Competency-based education in pharmacy: a review of its development, applications, and challenges. J Eval Clin Pract 26:1114–1123
Kiely PDW (2016) Biologic efficacy optimization- a step towards personalized medicine. Rheumatology 55:780–788
Kiles TM, Patel K, Aghagoli A, Spivey CA, Chisholm-Burns M, Hohmeier KC (2021) A community-based partnership collaborative practice agreement project to disseminate and implement evidence-based practices in community pharmacy. Curr Pharm Teach Learn 13:1522–1528
Lloyd GF, Bajorek B, Barclay P, Goh S (2015) Narrative review: status of key performance indicators in contemporary hospital pharmacy practice. J Pharm Pract Res 45:396–403
Mamo M, Wirth F, Azzopardi LM, Serracino-Inglott A (2013) Standardising pharmacist patient-profiling activities in a rehabilitation hospital in Malta. Eur J Hosp Pharm 21:49–53
Mantel-Teeuwisse AK, Meilianti S, Khatri B, Yi W, Azzopadi LM, Acosta Gomez J, Gulpinar G, Bennara K, Uzman N (2021) Digital health in pharmacy education: preparedness and responsiveness of pharmacy programmes. Educ Sci 296(11):296
McDonald KS, Hite LM (2008) The next generation of career success: implications of HRD. Adv Dev Hum Resour 10:86–103
Mifsud EM, Wirth F, Camilleri L, Azzopardi LM, Serracino-Inglott A (2019) Pharmacist-led medicine use review in community pharmacy for patients on warfarin. Int J Clin Pharm 41:741–750
Muscat Terribile C, Wirth F, Zammit MC, Vella J, Azzopardi LM, Serracino-Inglott A (2013) Evaluation of a quality system developed for pharmacy teaching laboratories. Pharm Educ 13(1):134–139
Njonkou G, Gbadamosi K, Muhammad S, Chughtai I, Le G, Fabayo A, Tran H, Lam B, Senay M, DeLaine L, McSwain C, Price DA (2021) Assessment of the impact of pharmacist-led transitions of care services in a primary health center. Hosp Pharm 56(3):187–190
O’Callaghan J, Barry SP, Bermingham M, Morris JM, Griffin BT (2019) Regulation of biosimilar medicines and current perspectives on interchangeability and policy. Eur J Clin Pharm 75:1–11
Osama S, Wirth F, Zahra G, Barbara C, Xuereb RG, Camilleri L, Azzopardi LM (2021) CYP2C19*2 genetic polymorphism and incidence of in-stent restenosis in patients on clopidogrel: a matched case-control study. Drug Metab Pers Ther 37(2):155–161
Paudyal V, Fialova D, Henman MC, Hazen A, Okuyan B, Lutters M, Cadogan C, Alves da Costa F, Galfrascoli E, Pudritz YM, Rydant S, Acosta-Gomez J (2021) Pharmacists’ involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy. Int J Clin Pharm 43:1139–1148
Pedersen CA, Schneider PH, Ganio MC, Scheckelhoff DJ (2019) ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education-2018. Am J Health Syst Pharm 76:1038–1058
Pedersen CA, Schneider PH, Ganio MC, Scheckelhoff DJ (2020) ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing-2019. Am J Health Syst Pharm 77:1026–1050
Pedersen CA, Schneider PH, Ganio MC, Scheckelhoff DJ (2021) ASHP national survey of pharmacy practice in hospital settings: dispensing and administration-2020. Am J Health Syst Pharm 78:1074–1093
Pham JT, Azzopardi LM, Lau AH, Jarrett JB (2019) Student perspectives on a collaborative international doctorate of pharmacy program. Pharmacy 7:85
Rajiah K, Sivarasa S, Maharajan MK (2021) Impact of pharmacists’ interventions and patients’ decision on health outcomes in terms of medication adherence and quality use of medicines among patients attending community pharmacies: a systematic review. Int J Environ Res Public Health 18:4392
Sammut Bartolo N, Ignas L, Wirth F, Attard-Pizzuto M, Vella Szijj J, Camilleri L, Serracino-Inglott A, Azzopardi LM (2020) Public perception of generic medicines in Malta. JPHRS 11(3):295–298
Scala D, Mucherino S, Wirth F, Valentina O, Polidori P, Faggiano ME, Iovine D, Saturnino P, Cattel F, Costantini A, Makoul G, Azzopardi LM, Menditto E (2022) Developing and piloting a Communication Assessment Tool assessing patient perspectives on communication with pharmacists (CAT-Pharm). Int J Clin Pharm. https://doi.org/10.1007/s11096-022-01382-y
Schumock GT, Meek PD, Ploetz PA, Vermuelen MS (1996) Economic evaluations of clinical pharmacy services. Pharmacotherapy 16(6):1182–1208
Scott S, May H, Patel M, Wright DJ, Bhattacharya D (2021) A practitioner behaviour change intervention for deprescribing in the hospital setting. Age Ageing 50:581–586
Serracino-Inglott A (2021) How to think like Francke for a global vision in challenging times. Am J Health Syst Pharm 78:606–612
Seychell M, Hackbart B (2013) The EU health strategy- Investing in health. Public Health Rev 35:4
Siaw MYL, Toh JH, Lee JY (2018) Patients’ perceptions of pharmacist-managed diabetes services in the ambulatory care and community settings within Singapore. Int J Clin Pharm 40:403–411
Slazak E, Cardinal C, Will S, Clark CM, Daly CJ, Jacobs DM (2020) Pharmacist-led transitions-of-care services in primary care settings: opportunities, experiences and challenges. J Am Pharm Assoc 60:443–449
Sternschein R, Hayes MM, Ramani S (2021) A model for teaching in learner-centred clinical settings. Med Teach 43:1450–1452
Strand MA, Bratberg J, Eukel K, Hardy M, Williams C (2020) Community pharmacists’ contribution to disease management during the COVID-19 pandemic. Prev Chronic Dis 17:E69
Stranges PM, Jackevicius CA, Anderson SL, Bondi DS, Danelich I, Emmons RP, Englin EF, Hansen ML, Nys C, Phan H, Philbrick AM, Rager M, Schumacher C, Smithgall S (2020) Role of clinical pharmacists and pharmacy support personnel in transitions of care. J Am Coll Clin Pharm 3:532–545
Sule A, Horak P, Makridaki D, Kohl S (2021) Hospital pharmacy specialisation. Eur J Hosp Pharm. https://doi.org/10.1136/ejhpharm-2021-002975
Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI (2020) An overview of clinical decision support systems: benefits, risks and strategies for success. NPJ Digit Med 17. https://doi.org/10.1038/s41746-020-0221-y
Thomson K, Hillier-Brown F, Walton N, Bilaj M, Bambra C, Todd A (2019) The effects of community pharmacy-delivered public health interventions on population health and health inequalities: a review of reviews. Prev Med 124:98–109
Tung EL, Thomas A, Eichner A, Shalit P (2018) Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care. Sex Health 15:556–561
Ulrick BY, Meggs EV (2019) Towards a greater professional standing: evolution of pharmacy practice and education, 1920–2020. Pharmacy 7:98
Ungaro S, Wirth F, Azzopardi LM, Serracino-Inglott A (2015) Point-of-care testing for urine analysis and microalbuminuria for diabetic patient management. Point Care 14:71–72
Vella M, Grima M, Wirth F et al (2015) Consumer perception of community pharmacist extended professional services. JPHRS 6:91–96
Vella J, Attard Pizzuto M, Sammut Bartolo N, Wirth F, Grech L, Pham J, Mactal Haaf C, Lau A, Serracino-Inglott A, Azzopadi LM (2021) A three-year post-graduate Doctorate in Pharmacy course incorporating professional, experiential and research activities: a collaborative innovative approach. MedEdPublish 10:93
Villeneuve Y, Courtemanche F, Firoozi F, Gilbert S, Desbiens MP, Desjardins A, Dinh C, LeBlanc VC, Attia A (2021) Impact of pharmacist interventions during transition of care in older adults to reduce the use of healthcare services: a scoping review. Res Soc Adm Pharm 17:1361–1372
Weeda E, Gilbert RE, Kolo SJ, Haney JS, Hazard LT, Taber DJ, Axon RN (2021) Impact of pharmacist-driven transitions of care interventions on post-hospital outcomes among patients with coronary artery disease: a systematic review. J Pharm Pract. https://doi.org/10.1177/08971900211064155
Westein MPD, de Vries H, Floor A, Koster AS, Buurma H (2019) Development of a postgraduate community pharmacist specialization program using CanMEDS competencies and entrustable professional activities. Am J Pharm Educ 83:1354–1365
Wirth F, Tabone F, Azzopardi LM, Gauci M, Zarb-Adami M, Serracino-Inglott A (2011) Consumer perception of the community pharmacist and community pharmacy services in Malta. JPHRS 1:189–194
Yee GC, Haas CE (2014) Standards of practice for clinical pharmacists: the time has come. Pharmacotherapy 34(8):769–770
Yemeke TT, McMillan S, Marciniak MW, Ozawa S (2021) A systematic review of the role of pharmacists in vaccination services in low- and middle-income countries. Res Soc Adm Pharm 17:300–306
Yeoman G, Furlong P, Seres M, Binder H, Chung H, Garzya V, Jones RRM (2017) Defining patient centricity with patients for patients and caregivers: a collaborative endeavour. BMJ Innov 3:76–83
Yu YM, Kim S, Choi KY, Jeong KY, Lee E (2019) Impact of knowledge, attitude and preceptor behaviour in pharmacovigilance education. Basic Clin Pharmacol Toxicol 124:591–599
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Azzopardi, L.M. (2023). How to Become a Successful Hospital and Community Pharmacist. In: Thomas, J.R., Saso, L., van Schravendijk, C. (eds) Career Options in the Pharmaceutical and Biomedical Industry . Springer, Cham. https://doi.org/10.1007/978-3-031-14911-5_16
Download citation
DOI: https://doi.org/10.1007/978-3-031-14911-5_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-14910-8
Online ISBN: 978-3-031-14911-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)